arrow
R

Roser Pinyol

University of Barcelona
H指数:26
被引数:7,960

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Activated ATF6α is a hepatic tumour driver restricting immunosurveillance

激活的ATF6α 是限制免疫监视的肝肿瘤驱动因素

Nature
IF48.5
2026-02-040
OA
Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling

突变扫描显示致癌CTNNB1突变对信号传导有不同的影响

2026-02-020
OAAI
Effective therapeutic targeting of CTNNB1-mutant hepatoblastoma with WNTinib

CTNNB1突变型肝母细胞瘤的有效治疗性靶向WNTinib

2025-12-010
OAAI
Artificial intelligence predicts outcome-related molecular profiles and vascular invasion in hepatocellular carcinoma

人工智能预测肝细胞癌的结局相关分子谱和血管侵犯

2025-09-110
OAAI
Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC
2024-11-010
OAAI
Tcf20 deficiency is associated with increased liver fibrogenesis and alterations in mitochondrial metabolism in mice and humans
2023-06-144
OAAI
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
2023-02-106
OA
Platelet GPIb alpha is a mediator and potential interventional target for NASH and subsequent liver cancer (vol 25, pg 641, 2019)
2022-02-184
OA
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis (vol 75, pg 865, 2021)

非酒精性脂肪性肝炎患者肝细胞癌的分子特征 (vol 75,pg 865,2021)

2021-12-012
OA
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

非酒精性脂肪性肝炎患者肝细胞癌的分子特征

2021-10-01148
OAAI
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma

肝外胆管癌的分子分型及治疗靶点

2020-08-01188
OAAI